Innoviva (INVA) Cash & Current Investments (2010 - 2026)
Innoviva (INVA) posted Cash & Current Investments of $579.06 million for Q2 2026, up 16.3% from $497.73 million a year earlier but down 5.4% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Innoviva's Cash & Current Investments came in at $566.67 million, up 37.4% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 18.1% (FY2020 to FY2025).
- In prior years, Innoviva's Cash & Current Investments was $412.5 million in FY2024 (+113.2%), $193.51 million in FY2023 (-33.5%), $291.05 million in FY2022 (+44.4%) and $201.53 million in FY2021 (-18.2%).
- Quarterly Cash & Current Investments has run from a low of $135.12 million in Q3 2021 to a high of $611.93 million in Q1 2026 over five years.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last seven quarters, with growth averaging 84.0% over the last seven quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q2 2022, with growth of 555.4%; the weakest was Q3 2021, with a decline of 71.8%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $611.93 million (Q1 2026), $566.67 million (Q4 2025) and $533.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Innoviva | 1.49 Bn | -801.70 Mn | 90.62 Mn | 579.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 579.06 Mn |
| Mar 31, 2026 | 611.93 Mn |
| Dec 31, 2025 | 566.67 Mn |
| Sep 30, 2025 | 533.10 Mn |
| Jun 30, 2025 | 497.73 Mn |
| Mar 31, 2025 | 446.88 Mn |
| Dec 31, 2024 | 412.50 Mn |
| Sep 30, 2024 | 260.63 Mn |
| Jun 30, 2024 | 217.00 Mn |
| Mar 31, 2024 | 178.36 Mn |
| Dec 31, 2023 | 193.51 Mn |
| Sep 30, 2023 | 180.00 Mn |
| Jun 30, 2023 | 173.03 Mn |
| Mar 31, 2023 | 144.05 Mn |
| Dec 31, 2022 | 291.05 Mn |
| Sep 30, 2022 | 301.07 Mn |
| Jun 30, 2022 | 283.58 Mn |
| Mar 31, 2022 | 216.80 Mn |
| Dec 31, 2021 | 201.53 Mn |
| Sep 30, 2021 | 135.12 Mn |
API Access
Innoviva Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();